Sandoz rabeprazole 20 mg supply disruption expected until early December
Sandoz Canada reports its rabeprazole sodium 20 mg enteric-coated tablet (DIN 02314185) faces an anticipated shortage from Oct 26 to Dec 4, 2026, after a disruption in the manufacture of the drug.
Rabeprazole is a commonly prescribed stomach-acid drug — prescribers and pharmacies should plan alternatives while the shortage is expected.
Shortage expected to end: 2026年12月4日 所有截止日期
询问关于此简报的内容
回答由AI根据此简报生成,可能存在错误。请在采取行动前核实原始来源。
无需账户每天可免费提问2次。会员可随时免费提问,次数不限。
非医疗、法律或移民建议。问题将匿名保存以改进我们的简报。
阅读原文
官方来源: Sandoz rabeprazole 20 mg supply disruption expected until early December (在新标签页中打开) — Health Product Shortages Canada